Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471357 | 0.81 | DPP4 (0.48) | HTR7 | |
| SCHEMBL29074270 | 0.79 | CYP19A1 (0.45) | CYP19A1HTR7PTGDR2ALDH1A1LMNA | |
| SCHEMBL19616161 | 0.79 | PTGDR2 (0.46) | CYP19A1HTR7PTGDR2POLBMAPK1 | |
| SCHEMBL5827236 | 0.78 | ALDH1A1 (0.47) | CYP19A1HTR7ALDH1A1LMNASCN2A | |
| SCHEMBL29141195 | 0.78 | POLB (0.49) | HTR7ALDH1A1LMNASCN2APOLB | |
| SCHEMBL9574293 | 0.77 | PTGDR2 (0.44) | CYP19A1HTR7PTGDR2LMNAPOLB | |
| SCHEMBL9194437 | 0.76 | DPP4 (0.58) | HTR7ALDH1A1LMNASCN2APOLB | |
| SCHEMBL9260 | 0.74 | ALDH1A1 (0.55) | ALDH1A1MAPK1MAOBHTTMAPT | |
| SCHEMBL1211 | 0.74 | IDO1 (0.61) | ALDH1A1POLBIDO1MAOBMAPT | |
| SCHEMBL6438986 | 0.74 | HTR7 (0.43) | CYP19A1HTR7ALDH1A1LMNASCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977065-A | FROM A PRODRUG | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-11-02 | — | — | US | claimed |
| EP-0638123-B1 | BACTERIAL NITROREDUCTASE FOR THE REDUCTION OF CB 1954 AND ANALOGUES THEREOF TO A CYTOTOXIC FORM | CANCER REC TECH LTD (GB) | 2006-12-27 | — | — | EP | disclosed |
| EP-0725826-B1 | IMPROVEMENTS RELATING TO CANCER THERAPY | CANCER RES CAMPAIGN TECH (GB) | 2005-01-26 | — | — | EP | disclosed |
| US-5977065-A | FROM A PRODRUG | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-11-02 | — | — | US | disclosed |
| US-5958682-A | VIRUS-DIRECTED ENZYME PRODRUG THERAPY FOR TREATING TUMOR CELLS CONSISTING OF A VIRAL VECTOR ENCODING BACTERIAL NITROREDUCTASE CAPABLE OF CONVERTING A PRODRUG INTO A CYTOTOXIC DRUG OPERABLY LINKED TO A PROMOTER; AND THE PRODRUG | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-09-28 | — | — | US | disclosed |
| US-5780585-A | Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1998-07-14 | — | — | US | disclosed |
| US-5770731-A | PROTECTING GROUPS, ANTIBODY DIRECTED ENZYME/PRODRUG THERAPY, ANTICARCINOGENIC AGENTS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1998-06-23 | — | — | US | disclosed |
| US-5728868-A | Prodrugs of protein tyrosine kinase inhibitors | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1998-03-17 | — | — | US | disclosed |
| US-5633158-A | CULTURE PRODUCT; GENETIC ENGINEERING | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1997-05-27 | — | — | US | disclosed |
| EP-0725826-A1 | IMPROVEMENTS RELATING TO CANCER THERAPY | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-08-14 | — | — | EP | disclosed |
| WO-1996014420-A1 | INDUCIBLE CELL ABLATION | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-05-17 | — | — | WO | disclosed |
| EP-0711177-A1 | IMPROVEMENTS RELATING TO PRODRUGS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-05-15 | — | — | EP | disclosed |
| EP-0708660-A1 | PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-05-01 | — | — | EP | disclosed |
| WO-1995012678-A2 | IMPROVEMENTS RELATING TO CANCER THERAPY | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-05-11 | — | — | WO | disclosed |
| EP-0638123-A1 | BACTERIAL NITROREDUCTASE FOR THE REDUCTION OF CB 1954 AND ANALOGUES THEREOF TO A CYTOTOXIC FORM | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-02-15 | — | — | EP | disclosed |
| WO-1995003830-A2 | PRODRUGS OF FARNESYL TRANSFERASE INHIBITORS FOR ADEPT OR VDEPT | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-02-09 | — | — | WO | disclosed |
| WO-1995002420-A2 | PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LTD. (GB) | 1995-01-26 | — | — | WO | disclosed |
| EP-0540263-A1 | Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993008288-A1 | BACTERIAL NITROREDUCTASE FOR THE REDUCTION OF CB 1954 AND ANALOGUES THEREOF TO A CYTOTOXIC FORM | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1993-04-29 | — | — | WO | disclosed |